34 completed, 6 terminated, 4 recruiting, 4 unknown. 24 Phase 2, 14 Phase 3, 4 Not applicable, 4 Phase 1, 3 Phase 4.
Follow Cutaneous Leishmaniasis: new trials by email Literature Review of Cutaneous Leishmaniasis trials Research Report on Cutaneous Leishmaniasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immersive Technology Headsets to Reduce Procedural Pain and Anxiety: Feasibility and Effects in Cutaneous Leishmaniasis Patients in Pakistan Virtual Reality - Cutaneous Leishmaniasis, Pain | Not applicable | Not yet recruiting | Stanford University | 15 | 2027-01-01 | 2026-10-05 |
| Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers A mobile app with AI functionality for diagnosing skin-related NTDs - Skin and Connective Tissue Diseases, Neglected Tropical Diseases | Not applicable | Not yet recruiting | Kenya Medical Research Institute | 2420 | 2026-05-01 | 2026-04-02 |
| Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis MILTEFOSINE gel - Cutaneous Leishmaniasis, Cutaneous Leishmaniasis, American | Phase 1 | Not yet recruiting | Universidad Industrial de Santander | 15 | 2026-01-01 | 2025-09-08 |
| Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup Thermotherapy - Cutaneous Leishmaniasis | Not applicable | Recruiting | Armauer Hansen Research Institute, Ethiopia | 103 | 2025-04-24 | 2026-10-16 |
| Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis Metronidazole - Cutaneous Leishmaniasis | Phase 2 | Recruiting | Hayder Adnan Fawzi | 40 | 2025-02-10 | 2025-02-14 |
| Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis Levofloxacin 0.5% - Cutaneous Leishmaniasis | Phase 2 | Recruiting | Hayder Adnan Fawzi | 40 | 2025-02-09 | 2025-09-30 |
| Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate Ciprofloxacin (BAYO9867), sodium stibogluconate (Pentostam) - Cutaneous Leishmaniasis | Phase 2 | Recruiting | Al-Mustafa University College | 80 | 2025-02-07 | 2025-09-30 |
| Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the Disease Clinical and epidemiological data, Parasitological samples, Assessment of clinical course and response to treatment - Cutaneous Leishmaniasis | Completed | Centre Hospitalier de Cayenne | 270 | 2023-04-01 | 2024-11-20 | |
| Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia Sodium Stibogluconate with allopurinol - Cutaneous Leishmaniasis | Completed | Institute of Tropical Medicine, Belgium | 105 | 2021-02-15 | 2024-03-18 | |
| Miltefosine and GM-CSF in Cutaneous Leishmaniasis Sbv, Miltefosine plus placebo, Miltefosine plus GM-CSF - Cutaneous Leishmaniasis | Phase 3 | Completed | Hospital Universitário Professor Edgard Santos | 300 | 2017-06-30 | 2020-04-07 |
| Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨ Miltefosine - Cutaneous Leishmaniasis | Phase 2 | Completed | Drugs for Neglected Diseases | 130 | 2016-12-01 | 2019-09-12 |
| Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco Cutaneous Leishmaniasis, Skin Diseases, Parasitic | Completed | National School of Public Health, Morocco | 219 | 2016-12-01 | 2017-08-08 | |
| Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients Pentostam - Cutaneous Leishmaniasis | Unknown | Sheba Medical Center | 100 | 2014-11-01 | 2014-11-03 | |
| High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus Fluconazole, Meglumine Antimoniate - Cutaneous Leishmaniasis | Phase 3 | Terminated | Hospital Universitário Professor Edgard Santos | 53 | 2014-02-01 | 2015-12-02 |
| Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia Topical Amphotericin B at 3% - Cutaneous Leishmaniasis | Phase 1 / Phase 2 | Completed | Drugs for Neglected Diseases | 80 | 2014-02-01 | 2016-07-26 |
| WR 279,396 for the Treatment of Cutaneous Leishmaniasis WR 279,396 - Cutaneous Leishmaniasis | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 18 | 2013-09-01 | 2017-01-25 |
| Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama WR 279,396, Paromomycin - Cutaneous Leishmaniasis | Phase 3 | Completed | U.S. Army Medical Research and Development Command | 399 | 2013-05-01 | 2018-02-14 |
| Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis Pentoxifylline, Placebo - Cutaneous Leishmaniasis | Phase 2 / Phase 3 | Completed | Paulo Roberto Lima Machado | 164 | 2012-03-01 | 2017-01-26 |
| WR 279,396 Open Label Treatment Protocol in Tunisia WR 279,396 topical cream - Cutaneous Leishmaniasis | Phase 2 | Terminated | U.S. Army Medical Research and Development Command | 50 | 2011-12-01 | 2014-12-19 |
| Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis Meglumine antimonate, Placebo, Pentoxifylline - Cutaneous Leishmaniasis | Phase 2 / Phase 3 | Completed | Centro Internacional de Entrenamiento e Investigaciones Médicas | 75 | 2011-11-01 | 2016-08-23 |
Showing 20 of 52. Sign in to see all of them.
Leishmaniasis, Cutaneous (52) · Leishmaniasis (13) · Hyperthermia (3) · Leishmaniasis, Mucocutaneous (2) · Neglected Diseases (2) · Anxiety Disorders (1) · Buruli Ulcer (1) · Cicatrix (1) · Elephantiasis (1) · Elephantiasis, Filarial (1) · Hypersensitivity, Delayed (1) · Leprosy (1) · Mycetoma (1) · Onchocerciasis (1) · Pain (1)
Euglenozoa Infections (52) · Infections (52) · Protozoan Infections (52) · Skin Diseases (52) · Skin Diseases, Infectious (52) · Parasitic Diseases (51) · Skin Diseases, Parasitic (51) · Skin and Connective Tissue Diseases (51) · Vector Borne Diseases (51) · Leishmaniasis (39) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (4) · Body Temperature Changes (3) · Heat Stress Disorders (3) · Pathologic Processes (3)
Meglumine Antimoniate (12) · miltefosine (10) · Antimony Sodium Gluconate (6) · Antimony (2) · Cryotherapy (2) · Hyperthermia, Induced (2) · Imiquimod (2) · Paromomycin (2) · Pentoxifylline (2) · Allopurinol (1) · Azithromycin (1) · Ciprofloxacin (1) · Contraceptives, Oral (1) · Diathermy (1) · Fluconazole (1)
U.S. Army Medical Research and Development Command (7) · Access to Advanced Health Institute (AAHI) (3) · Centro Internacional de Entrenamiento e Investigaciones Médicas (3) · Drugs for Neglected Diseases (3) · Hospital Universitário Professor Edgard Santos (3) · Tehran University of Medical Sciences (3) · Foundation Fader (2) · Hadassah Medical Organization (2) · Hayder Adnan Fawzi (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · AB Foundation (1) · Al-Mustafa University College (1) · Ana Rabello (1) · Armauer Hansen Research Institute, Ethiopia (1) · Assistance Publique - Hôpitaux de Paris (1)
Colombia (9) · Brazil (7) · United States (5) · Bolivia (4) · Tunisia (4) · Ethiopia (3) · Iran (3) · Iraq (3) · Israel (3) · Peru (3) · France (2) · Mali (2) · Democratic Republic of the Congo (1) · India (1) · Kenya (1)
Afif Ben Salah, M.D., Ph.D. (3) · Alejandro Llanos-Cuentas, MD, PhD (2) · Ivan Dario Velez, Prof (2) · Nancy C Saravia, PhD (2) · Ali Khamesipour (1) · Ali Khamesipour, MPH, PhD (1) · Ali Khamesipour, PhD (1) · Alireza Khatami, MD MSPH (1) · Ana Rabello, MD PhD (1) · Armando O. Schubach, MD, PhD (1) · Catherine Royce, Dr (1) · Christian F Rueda-Clausen, MD (1)
PMID 28379954, PMID 11353640, PMID 19415122, PMID 19636365, PMID 20016847, PMID 20231896, PMID 20438389, PMID 22238470, PMID 22594858, PMID 23388004, PMID 23390069, PMID 23740007, PMID 27803094, PMID 27956421, PMID 28558061, PMID 29898753, PMID 29988004, PMID 30044792, PMID 30815688, PMID 32894278, PMID 33253864, PMID 35255096, PMID 37624352